Merck's market opportunities lie in its broad biopharmaceutical offerings, targeting oncology, vaccines, and more, alongside extensive veterinary solutions. Its tech-driven innovations, strategic partnerships, and global presence enhance its competitive edge in healthcare and digital transformation initiatives.
Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Merck & Co., Inc. 2025" company profile has been added to ResearchAndMarkets.com's offering.
The report provides insights into company's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Merck & Co Inc (Merck) is a biopharmaceutical company that discovers, develops, manufactures, and markets medicines, vaccines, biologic therapies, and animal health products.
The company offers prescription medicines under the therapy areas of oncology, vaccines, infectious diseases, cardio-metabolic disorders, immunology, neuroscience, and ophthalmology. It also offers a wide range of veterinary pharmaceuticals; vaccines; health management solutions and services; and identification, traceability, and monitoring products.
Merck's products are provided to drug wholesalers, retailers, hospitals, government agencies, health maintenance organizations, pharmacy benefit managers, other institutions, veterinarians, distributors, animal producers, farmers, and pet owners. It operates manufacturing facilities in North America, South America, Western Europe, Africa, and Asia. Merck is headquartered in Rahway, New Jersey, the US.
The report provides information and insights into Merck's tech activities, including:
Insights of its digital transformation strategies and innovation programs.
Overview of technology initiatives covering partnerships, product launches, investments, and acquisitions.
Insights on each technology initiative including technology theme, objective, and benefits.
Details of estimated ICT budgets and major ICT contracts.
Reasons to Buy
Gain insights into Merck's tech operations.
Gain insights into its tech strategies and innovation initiatives.
Gain insights into its technology themes under focus.
Gain insights into various product launches, partnerships, investments, and acquisitions.
Key Topics Covered:
Merck's Overview
Merck's Digital Transformation Strategy
Merck's Accelerators, Incubators, and Innovation Programs
Merck's Technology Focus
Merck's Technology Initiatives
Merck's Venture Arm
Merck's Investments
Merck's Acquisitions
Merck's Tech Ecosystem
Merck's ICT Budget & Contracts
Merck's Senior Management Team
Our Thematic Scorecard for the Pharmaceuticals and Healthcare Sector
Companies Featured
McKinsey & Company
Boston Consulting Group
Unnatural Products
Variational AI
Vector Institute
D4H
Amazon
Evaxion Biotech
Mila
Owkin
Saama
Absci
Hyfe
Philips
Natera
Evidation
Syapse
Corning
Seeq
SAP
IBM
KPMG
Walmart
Google Cloud
Veeva Systems
Appian
For more information about this company profile visit https://www.researchandmarkets.com/r/b96loe
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900